Sanofi
- All
- News
- Videos
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Sanofi And GSK Launch Final Testing Phase Of New Covid Vaccine
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
Sanofi, GSK Covid Vaccine To Be Ready Only At The End Of 2021
France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Sanofi Pledges Coronavirus Vaccine For All After French Backlash
Sanofi chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying some countries would get priority access.
-
France Fumes As Paris-Based Sanofi Says US To Have First Dibs On Vaccine
The French government cried foul Thursday after pharmaceutical giant Sanofi said it would reserve first shipments of any COVID-19 vaccine for the United States, saying the move would be "unacceptable" in a crisis that has killed nearly 300,000 people worldwide.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Sanofi And GSK Launch Final Testing Phase Of New Covid Vaccine
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
Sanofi, GSK Covid Vaccine To Be Ready Only At The End Of 2021
France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
-
French Drugmaker Sanofi Expects Approval Of COVID-19 Vaccine By Next Year
French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
-
Sanofi Pledges Coronavirus Vaccine For All After French Backlash
Sanofi chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying some countries would get priority access.
-
France Fumes As Paris-Based Sanofi Says US To Have First Dibs On Vaccine
The French government cried foul Thursday after pharmaceutical giant Sanofi said it would reserve first shipments of any COVID-19 vaccine for the United States, saying the move would be "unacceptable" in a crisis that has killed nearly 300,000 people worldwide.
